IMPACT THERAPEUTICS

Filed: July 24, 2023
Targeted anti-cancer therapeutics based on synthetic lethality technology; Pharmaceutical products for the prevention and…
Owned by: Nanjing Impact Therapeutics Co., Ltd.
Serial Number: 98098664